“What about the Golo reducing pills for former cancer patients?”

I am currently out of the office and will be checking emails sporadiacally. For patient related questions please contact 470 733 4783 during office hours; For non-patient related questions please contact Robin Worthy at 404 778 1436,


Nabil F Saba MD, FACP,
Professor,Hematology and Medical Oncology,
Professor of Otolaryngology,
Director of the Head and Neck Oncology Program,
Winship Cancer institute of Emory University
1365 Cliffton Rd, C-2110
Atlanta, GA 30322
Phone: 404 778 3995
Fax: 404 778 3995

I am out of the office until Monday February 3rd on vacation.

I will be checking emails at a reduced frequency and unable to respond in real time.

Please see below for my coverage options:

Patients or patient related issues can be directly to the breast clinic at 720-848-1030 or through my pager 303-266-0178, which will be covered by Dr. Elias or NP Colleen Dougherty-Gray. During times of clinic closure, please call the hospital operator to reach the hematology-oncology fellow on call. New patient referrals should be directed to 720-848-1030 or nicole.sisen@ucdenver.edu.
Borges Lab or lab research issues should be directed to Michelle Borakove, lab manager, at 303-724-0178.
Breast Cancer Clinical Research issues to Gwen.wade@cuanschtuz.edu.
ORIEN issues to kyra.anderson@cuanschutz.edu

Thank you for your message. I am currently out-of-the-office, returning January 27, 2020.

Aminah Jatoi

Any weight loss in remission cancer pts must be under supervision have a medical not cosmetic motive and monitor that immune function doesn't suffer. The role of weight "control" slow loss remission breast cancer surgery is positive and should be supervised & achieved with close to normal life style measures.